The Global Alliance for Vaccines and Immunization is devoting $100.2 million to efforts aimed at curbing meningitis A in Cameroon, Chad and Nigeria.
The funding will be used to introduce MenAfriVac, which was launched in December 2010 in Burkina Faso and has been distributed in two other African countries, Mali and Niger. GAVI expects the vaccine to avert 150,000 deaths by 2015.
“We accelerated our approvals process so that we can ensure this vaccine is available in Cameroon, Chad, and Nigeria, before next year’s epidemic season due to start in December,” said GAVI’s interim CEO, Helen Evans.
Read more development aid news.